Metropolitan Life Insurance CO Akebia Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

47 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.32 - $0.67 $3,749 - $7,851	-11,718 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$0.72 - $2.93 $8,436 - $34,333	11,718 New	11,718 $8,000
Q1 2022 Mar 30, 2023	SELL	$0.72 - $2.93 $21,909 - $89,159	-30,430 Reduced 72.2%	11,718 $8,000
Q1 2022 May 12, 2022	SELL	$0.72 - $2.93 $21,909 - $89,159	-30,430 Reduced 72.2%	11,718 $8,000
Q4 2021 Jun 21, 2023	BUY	$2.26 - $3.34 $95,254 - $140,774	42,148 New	42,148 $95,000
Q4 2021 Mar 30, 2023	SELL	$2.26 - $3.34 $13,709 - $20,260	-6,066 Reduced 12.58%	42,148 $95,000
Q4 2021 Feb 15, 2022	SELL	$2.26 - $3.34 $13,709 - $20,260	-6,066 Reduced 12.58%	42,148 $95,000
Q3 2021 Jun 21, 2023	BUY	$2.35 - $3.88 $113,302 - $187,070	48,214 New	48,214 $138,000
Q3 2021 Mar 30, 2023	BUY	$2.35 - $3.88 $47,608 - $78,604	20,259 Added 72.47%	48,214 $138,000
Q3 2021 Nov 15, 2021	BUY	$2.35 - $3.88 $47,608 - $78,604	20,259 Added 72.47%	48,214 $139,000
Q2 2021 Jun 21, 2023	BUY	$2.83 - $4.2 $79,112 - $117,411	27,955 New	27,955 $105,000
Q2 2021 Mar 30, 2023	SELL	$2.83 - $4.2 $44,411 - $65,910	-15,693 Reduced 35.95%	27,955 $105,000
Q2 2021 Aug 16, 2021	BUY	$2.83 - $4.2 $78,988 - $117,226	27,911 Added 63434.09%	27,955 $106,000
Q1 2021 Jun 26, 2023	BUY	$2.92 - $5.06 $127,452 - $220,858	43,648 New	43,648 $148 Million
Q1 2021 Mar 30, 2023	BUY	$2.92 - $5.06 $62,785 - $108,800	21,502 Added 97.09%	43,648 $147,000
Q1 2021 May 14, 2021	SELL	$2.92 - $5.06 $64,537 - $111,836	-22,102 Reduced 99.8%	44 $148,000
Q4 2020 Jun 22, 2023	BUY	$2.22 - $3.78 $49,164 - $83,711	22,146 New	22,146 $62,000
Q4 2020 Mar 30, 2023	BUY	$2.22 - $3.78 $7,881 - $13,419	3,550 Added 19.09%	22,146 $62,000
Q4 2020 Feb 16, 2021	BUY	$2.22 - $3.78 $7,881 - $13,419	3,550 Added 19.09%	22,146 $62,000
Q3 2020 Jun 26, 2023	BUY	$2.39 - $13.08 $44,444 - $243,235	18,596 New	18,596 $46,000
Q3 2020 Mar 30, 2023	SELL	$2.39 - $13.08 $51,569 - $282,227	-21,577 Reduced 53.71%	18,596 $46,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $13.08 $51,569 - $282,227	-21,577 Reduced 53.71%	18,596 $47,000
Q2 2020 Jun 26, 2023	BUY	$6.67 - $13.58 $267,953 - $545,549	40,173 New	40,173 $545,000
Q2 2020 Mar 30, 2023	BUY	$6.67 - $13.58 $22,097 - $44,990	3,313 Added 8.99%	40,173 $545,000
Q2 2020 Aug 14, 2020	BUY	$6.67 - $13.58 $22,097 - $44,990	3,313 Added 8.99%	40,173 $546,000
Q1 2020 Jul 12, 2023	BUY	$4.1 - $10.24 $151,126 - $377,446	36,860 New	36,860 $279,000
Q1 2020 Mar 30, 2023	SELL	$4.1 - $10.24 $7,015 - $17,520	-1,711 Reduced 4.44%	36,860 $279,000
Q1 2020 May 15, 2020	SELL	$4.1 - $10.24 $7,015 - $17,520	-1,711 Reduced 4.44%	36,860 $279,000
Q4 2019 Jul 12, 2023	BUY	$3.16 - $6.73 $121,884 - $259,582	38,571 New	38,571 $243,000
Q4 2019 Mar 30, 2023	BUY	$3.16 - $6.73 $27,833 - $59,277	8,808 Added 29.59%	38,571 $243,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $27,833 - $59,277	8,808 Added 29.59%	38,571 $244,000
Q3 2019 Jul 12, 2023	BUY	$3.55 - $5.4 $105,658 - $160,720	29,763 New	29,763 $116,000
Q3 2019 Mar 30, 2023	SELL	$3.55 - $5.4 $9,332 - $14,196	-2,629 Reduced 8.12%	29,763 $116,000
Q3 2019 Nov 14, 2019	SELL	$3.55 - $5.4 $9,332 - $14,196	-2,629 Reduced 8.12%	29,763 $117,000
Q2 2019 Jul 12, 2023	BUY	$4.1 - $8.05 $143,836 - $282,410	35,082 New	35,082 $169,000
Q1 2019 Jul 13, 2023	BUY	$5.41 - $8.73 $175,240 - $282,782	32,392 New	32,392 $265,000
Q1 2019 Mar 30, 2023	BUY	$5.41 - $8.73 $175,240 - $282,782	32,392 New	32,392 $265,000
Q1 2019 May 16, 2019	BUY	$5.41 - $8.73 $58,271 - $94,030	10,771 Added 49.82%	32,392 $265,000
Q1 2019 May 15, 2019	SELL	$5.41 - $8.73 $58,330 - $94,126	-10,782 Reduced 33.27%	21,621 $245,000
Q4 2018 Jul 13, 2023	BUY	$5.39 - $9.15 $174,652 - $296,487	32,403 New	32,403 $179,000
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $154,008 - $261,442	28,573 Added 746.03%	32,403 $179,000
Q3 2018 Jul 13, 2023	BUY	$7.44 - $10.65 $154,446 - $221,083	20,759 New	20,759 $183 Million
Q3 2018 Nov 14, 2018	SELL	$7.44 - $10.65 $125,951 - $180,293	-16,929 Reduced 81.55%	3,830 $34,000
Q2 2018 Aug 15, 2018	BUY	$9.15 - $11.34 $60,188 - $74,594	6,578 Added 46.39%	20,759 $0
Q4 2017 Feb 15, 2018	SELL	$14.24 - $19.59 $224,422 - $308,738	-15,760 Reduced 52.64%	14,181 $211,000
Q3 2017 Nov 14, 2017	BUY	$13.06 - $19.67 $79,888 - $120,321	6,117 Added 25.68%	29,941 $589,000
Q2 2017 Aug 14, 2017	BUY	N/A	23,824	23,824 $342,000

Others Institutions Holding AKBA

# of Institutions

110

Shares Held

55.3M

Call Options Held

554K

Put Options Held

246K

Black Rock Inc. New York, NY

11.6M
Shares

$15.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

9.28M
Shares

$12.3 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$7.64 Million
11.5% of portfolio
Geode Capital Management, LLC Boston, MA

4.54M
Shares

$6.03 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

4.06M
Shares

$5.4 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $245M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account